Mergers: Commission approves GlaxoSmithKline’s acquisition of Pfizer’s Consumer Health Business, subject to conditions

drugs

(Joshua Coleman, Unsplash)

This article is brought to you in association with the European Commission.


The European Commission has approved, under the EU Merger Regulation, the acquisition of Pfizer’s Consumer Health Business by GlaxoSmithKline. The decision is conditional upon the global divestment of Pfizer’s topical pain management business carried out under the ThermaCare brand.

GlaxoSmithKline (“GSK”) and Pfizer’s Consumer Health Business are both manufacturers and suppliers of a variety of consumer healthcare pharmaceuticals, which are typically available to patients without a prescription from a doctor and generally referred to as “over-the-counter” (“OTC”) pharmaceutical products.

Both companies are active in the European Economic Area (“EEA”) in a number of OTC product categories, namely topical pain management (creams, gels, spays and patches to treat pain locally), systemic pain management (products for oral intake targeting pain centrally), cold and flu treatments (e.g. multi-symptom treatments, antitussives), gastrointestinal treatments (e.g. antiacids, antiflatulents, antiulcerants), nutrition and digestive health (e.g. vitamins, supplements, laxatives), as well as sedatives and sleeping aids.

The Commission’s investigation

The Commission examined the effects of the proposed transaction on competition in the markets where the activities of the companies overlap.

Based on the investigation, the Commission was concerned that the acquisition would reduce competition for topical pain management products, possibly resulting in price increases in a number of EEA countries, including Austria, Germany, Ireland, Italy and the Netherlands.

In the market for topical pain management products,the Commission found products to be broadly substitutable irrespective of their different format or composition (e.g. patches and gels, medicated or not).

For topical pain management products, GSK is a leading OTC supplier in the EEA with its range of Volta-branded products (including VoltarenVoltadol, or Voltarol). These products are mainly sold as medicated gel, creams or spray but also as medicated and non-medicated patches. Pfizer is mostly active in the EEA with its range of ThermaCare-branded products, which consists mainly of non-medicated patches.

The proposed remedies

To address these concerns, the companies offered to divest Pfizer’s topical pain management business carried out under the ThermaCarebrand globally. This includes all relevant assets that contribute to the current operation or are necessary to ensure the viability and competitiveness thereof.

These assets will have to be divested as a package to one suitable purchaser to be approved by the Commission. The commitments provide in particular for the divestiture of a Pfizer manufacturing facility located in the US, which is dedicated to the production of ThermaCare products, of all intellectual property rights relating to the ThermaCare products and brand, as well as products under development.

These commitments remove almost entirely the overlaps between GSK and Pfizer’s Consumer Health Business in the topical pain management category in the EEA.

Therefore, the Commission concluded that the proposed transaction, as modified by the commitments, would no longer raise competition concerns in the EEA. The Commission’s decision is conditional upon full compliance with the commitments.

Companies and products

GSK, based in the UK, is a pharmaceuticals company active worldwide in research, development, manufacturing, and marketing in three broad segments, i.e. prescription pharmaceuticals, vaccines, and consumer healthcare products.

Pfizer, based in the US, is a pharmaceuticals company active worldwide in the research, development, manufacturing and marketing of innovative medicines. Pfizer’s Consumer Health Businessoffers products in five major areas: (a) pain management; (b) gastrointestinal health; (c) respiratory; (d) dietary supplements, and (e) personal care products (e.g. lip care).

Merger control rules and procedures

The transaction was notified to the Commission on 17 May 2019.

The Commission has the duty to assess mergers and acquisitions involving companies with a turnover above certain thresholds (see Article 1 of the Merger Regulation) and to prevent concentrations that would significantly impede effective competition in the EEA or any substantial part of it.

The vast majority of notified mergers do not pose competition problems and are cleared after a routine review. From the moment a transaction is notified, the Commission generally has a total of 25 working days to decide whether to grant approval (Phase I) or to start an in-depth investigation (Phase II). This deadline is extended to 35 working days in cases where remedies are submitted by the parties, such as in this case.

Advertising

Advertising

Advertising

Advertising

Advertising

Advertising

Advertising

Advertising

Advertising

Advertising

Advertising

Advertising

Advertising

the European Sting Milestones

Featured Stings

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

Rare Disease Day: a new EU platform to support better diagnosis and treatment

UN chief welcomes ‘first concrete step’ in normalizing Eritrea-Ethiopia relationship

Brexit: UK to suffer from EU’s uncompromising stance

Drug laws must be amended to ‘combat racial discrimination’, UN experts say

Your chocolate can help save the planet. Here’s how

Baby foods high in sugar, inappropriately marketed in Europe, reveal two UN studies

11 lessons the history of business can teach us about its future

The Banking Union divides deeply the European Union

Brexit update: Will Theresa May’s last-minute desperate efforts procrastinate Brexit?

GradList Launched At TheNextWeb 2014

Medical students: The need for emigration

More answers from Facebook ahead of Parliament hearing today

JADE President opens JADE Spring Meeting 2014

Want more climate action? Let’s show how good a planet-friendly life can be

The key takeaways of G7 Summit in Canada

New rules for short-stay visas: EP and Council reach a deal

Now doctors can manipulate genetics to modify babies, is it ethical?

More billions needed to help Eurozone recover; ECB sidesteps German objections about QE

Eurozone: Black economy loves the South

Brands can be a force for good and for growth. Here’s how

Six children among 53 confirmed fatalities after Libya detention centre airstrikes: Security Council condemns attack

3 reasons why business leaders can’t afford to ignore diversity

A Sting Exclusive: “Europe needs decisive progress for stronger cybersecurity”, EU Commissioner Gabriel highlights from Brussels

WEF Davos 2016 LIVE: Cameron corroborates that Britain should remain in the EU

European Parliament the most trusted EU institution

Close to 7,000 evacuated from Syrian towns after enduring nearly 3-year siege

Young people worldwide can ‘determine the future of migration,’ says UN senior official

OECD joins with Japan to fight financial crime by establishing new academy

Russia can no longer be considered a ‘strategic partner’, say MEPs

COP24: Paris agreement remained alive but fragile while the EU attempts to slow down CO2 emissions for new cars

Entrepreneurial leadership: what does it take to become a leader?

The challenges of mental health: an inconvenient reality

Illegal fishing: EU lifts Taiwan’s yellow card following reforms

MEPs propose more transparent legislative drafting and use of allowances

IMF: Sorry Greece it was a mistake of 11% of your GDP

The Sting’s Values

How bad is the Eurozone economy? The ECB thinks too bad

Why women aren’t allowed to work

Good grub: why we might be eating insects soon

Venezuela: Parliament recognises Guaidó, urges EU to follow suit

How civil society can adapt to the Fourth Industrial Revolution

The financial war touches Frankfurt and Berlin

What have the banks done to the markets making them unable to bear cheap oil?

Climate change hits the poor hardest. Mozambique’s cyclones prove it

SPB TV @ MWC14: The TV of the Future

Pollution could be harming every part of your body. Here’s how

ISIS fighters fleeing Mosul for Syria can topple Assad. Why did the US now decide to uproot them from Iraq?

Mediterranean migrant drownings should spur greater action by European countries, urge UN agencies

Three ways China can make the New Silk Road sustainable

MWC 2016 LIVE: Mobile World Congress shows off planes, trams and automobiles

Who really cares for the environment?

Budget MEPs approve €34m in EU aid to Greece, Poland, Lithuania and Bulgaria

World cannot be transformed without ‘ingenuity of the countries of the South’: UN Chief

Knowledge management and entrepreneurship: short term vs. long term perspective

Germany resists Macron’s plan for closer and more cohesive Eurozone; Paris and Berlin at odds

3 charts that show how global carbon emissions hit a record high in 2018

How India’s globalized cities will change its future

The world’s most expensive places to own a home

Appalling overall unemployment in Eurozone at 20.6%

Donor countries need to reform development finance to meet 2030 pledge

More Stings?

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s